There are countless reasons why I will be attending the ISPE 2017 Europe Annual Conference, but for the sake of time, I’ve narrowed it down to my top three.
April 4th – Accelerated Development – Afternoon Session The industry and regulatory speakers will touch on trends and potential solutions, including faster selection of drug candidates and clinical trials with Advanced Therapy Medicinal Products (ATMP).
April 5th – GDP & GMP Annex 15 Risk Management – Morning Session You will get brand new regulatory updates and hear various case studies. One focus will be on Direct-to-Patient supplies. Share and learn more in a planned risk based distribution workshop.
April 5th – Patient Centricity & Innovative Supply Chain Approaches – Afternoon Session Listen to patient representatives, clinical supply chain and technology experts and discuss how value can be created for patients in clinical trials.
I’m looking forward to this unique opportunity to enhance my technical knowledge, exchange ideas with my peers, and gain insight from industry experts. I’m looking forward to seeing you at the 2017 ISPE Europe Annual Conference! By: Jens Mattuschka World Courier, an AmerisourceBergen company RVP | Nordics, Central and Eastern Europe
Stability sampling and testing are key to ensuring that products maintain safety, identity, strength, purity, and quality throughout their claimed shelf life. It is also a regulatory requirement per ICH Q5. However, storing product samples in different environmental conditions, testing those samples for three to five years (or more) after initial manufacture, and properly analyzing and...
ISPE hosted more than 450 attendees in person and virtually for the 2024 ISPE Aseptic Conference in Vienna, Austria. Keynotes and education sessions provided a comprehensive overview of key topics and trends...
Biopharmaceutical facility design is a critical aspect of the industry. Overall cost pressures in the global health system, regional requirements to deploy manufacturing rather than centralize manufacturing in one location, technology enhancements in cell biology and format, flexibility to accommodate multi-product campaigns with different production schedules, and speed-to-market are among...